ArticleClinical rheumatology2025
Exploration of common genomic signatures of systemic juvenile idiopathic arthritis and Kawasaki disease.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesTo explore shared genetic characteristics and potential molecular processes in systemic juvenile idiopathic arthritis (SJIA) and Kawasaki disease (KD), microarray data for both conditions were retrieved and analyzed from the Gene Expression Omnibus (GEO) database.
methodsThe researchers utilized the ExpressAnalystR software to identify the differentially expressed genes (DEGs) shared between the diseases and subsequently pinpointed genes associated with extracellular proteins within this set. Transcription factors (TFs) and their corresponding target genes in single-domain encoding genes (SDEGs) were identified through a comparative analysis of databases such as HumanTFDB and hTFtarget. These gene sets then underwent functional enrichment analysis using the Metascape program. Finally, immune infiltration analysis was performed using CIBERSORT.
resultsThe study identified a total of 204 upregulated and 35 downregulated SDEGs. A network targeting transcription factors revealed four specific TFs (EGR1, BCL6, FOS, and NFE2), which were further examined. The functional enrichment analysis and immune infiltration findings suggest that both adaptive and innate immune systems play key roles in the development of SJIA and KD. Signaling pathways, such as NF-kB, are critical to the pathogenesis of these diseases, alongside biological processes such as tumor necrosis factor (TNF) functions and neutrophil degranulation.
conclusionThe findings of this study provide substantial evidence of the complex and dynamic immune system abnormalities underlying SJIA and KD. A common pathogenic mechanism may involve TNF activity, neutrophil degranulation, and the NF-kB pathway. Additionally, a more detailed investigation into the regulatory roles of EGR1, BCL6, FOS, and NFE2 within this network is essential. Key Points • The study retrieved and analyzed microarray data for both conditions from the Gene Expression Omnibus (GEO) database,to investigate the common genetic patterns and potential molecular processes involved in systemic juvenile idiopathic arthritis (SJIA) and Kawasaki disease (KD). • The study identified a total of 204 upregulated and 35 downregulated SDEGs. A network targeting transcription factors revealed four specific TFs (EGR1, 20BCL6, FOS, and NFE2), which were further examined. • The findings of this study provide substantial evidence of the complex and dynamic immune system abnormalities underlying SJIA and KD. A common pathogenic mechanism may involve TNF activity, neutrophil degranulation, and the NF-kB pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.